PIAS3 and breast carcinoma: The prognostic value of a single SUMO machinery component can also vary between cancer (sub)types, and, e.g., the value for PC2 [61,62] and PIAS4 [63,64] as prognostic biomarkers in breast cancer and for PIAS3 [65,66] in mesothelioma remains ambiguous (Table 1).